Penile Prosthesis Implantation in Refractory Ischaemic Priapism: Patient Selection and Special Considerations
Marco Capece,Marco Falcone,Tommaso Cai,Alessandro Palmieri,Andrea Cocci,Roberto La Rocca
DOI: https://doi.org/10.2147/RRU.S278807
2022-01-14
Research and Reports in Urology
Abstract:Marco Capece, 1 Marco Falcone, 2 Tommaso Cai, 3 Alessandro Palmieri, 1 Andrea Cocci, 4 Roberto La Rocca 1 1 Department of Urology, AOU Federico II, University Hospital, Naples, Italy; 2 Department of Neurourology, A.O.U. Città della Salute e della Scienza di Torino - Unità Spinale Unipolare, Turin, Italy; 3 Ospedale Santa Chiara, Trento, Italy; 4 Department of Oncologic, Minimally-Invasive Urology and Andrology, Careggi Hospital, University of Florence, Florence, Italy Correspondence: Alessandro Palmieri Department of Neuroscience, Reproductive Science and Odontostomatology, University Federico II of Naples, via S.Pansini 5, Naples, 80131, Italy Tel +39 081 746 2611 Fax +39 081 746 4311 Email Ischemic priapism accounts for more than 95% of all priapic episodes. It has to be considered a urological emergency because its time extension may lead to necrosis of smooth muscle cells of the corpora cavernosa, resulting in a complete erectile dysfunction, penile shortening and loss of girth. In the present systematic review, we perform an up-to-date literature search for patients suffering from refractory ischemic priapism who undergo penile prosthesis implantation with particular interests to the patients characteristics. The conservative management of the priapic episode consists of a sympathomimetic agent in the first istance. Failure or recurrence of priapism following these conservative measures is an indication for surgical management. Shunt procedures between the corpora cavernosa and the neighbouring structures are often used first line; however, in refractory ischemic priapism the success rate is minimal. In such cases (> 48 h) an indication of immediate placement of a penile prosthesis could be the best solution. Keywords: refractory ischemic priapism, erectile dysfunction, priapism, penile prosthesis Ischemic priapism is a rare condition that has an incidence of 1–1.5 cases every 100.000 people. 1 The pathological mechanism of this condition is due to the obstruction of penile venous outflow, which causes a hypoxic blood stasis within the corpus cavernosum leading to a peculiar compartment syndrome. 2–4 If the blood stagnation remains for more than 24 hours, smooth muscle cell (SMC) necrosis begins and the risk of developing a refractory erectile dysfunction is more than 90%. 5 After 48–72 hours there are zero chances of recovering erectile dysfunction. 6 Once the diagnosis of ischemic priapism is confirmed an initial conservative management is usually attempted. This consists of physical exercise, cold shower or ejaculation, in order to facilitate the SMC contraction. After these attempts, trans-glandular corporal irrigation followed by instillation of α-agonists represent the most beneficial option, being determinant in more than 36% of cases. 1,2 Unfortunately, the remaining part of the patients do not respond to α-agonists either. At this stage, the smooth muscle damage has already occurred. Surely shunt surgery is more effective, however it can only solve the priapic episode leaving the issue of erectile dysfunction. 7 The Winter shunt is the most common procedure, and its aim is to create a fistula between the spongiosa and the corpora cavernosa, in order to literally "shunt" the blood in a different venous system. On the other hand, this fistula may result in a refractory erectile dysfunction. In addition to that, the inevitable fibrosis of the corpora cavernosa causes a certain degree of shortening of the penis which worsen the already compromised situation. 6,8 Thus, in such cases the implantation of a penile prosthesis may represents the only solution either to solve the priapism and to restore the erectile function and to minimize the shortening of the penis. The surgical procedure of penile prosthesis implantation (PPI) can be seriously challenging due to the diffuse corporal fibrosis and the later patient undergoes surgery the more difficult the implant becomes. 9 PPI can be performed either in the "early" phase of the refractory ischemic priapism (RIP), or at a later stage when refractory erectile dysfunction and penile shortening have already occurred. In the present review, the authors evaluate the up-to-date literature and will focus on the characteristics of patients undergoing penile prosthesis implantation after RIP and the type of device used. A systematic search has been performed using the terms "ischemic priapism", "refractory erectile dysfunction", "fibrosis", "penile implant", "immediate implantation", "delayed implantation" using Pubmed and EMBASE search engines. The systematic review has not been registered on PROSPERO as "PROSPERO does not currently accept registrations for sc -Abstract Truncated-